X
skip to main content
Logo
media conference

Press Releases

  • September 06, 2017

    A recent study by a prolific TFRI-funded team has demonstrated that disrupting ERG transcriptional activity is sufficient to suppress the major characteristics of ERG-transformed prostate cancers.

  • September 06, 2017

    Ontario cancer researchers have found that an oncolytic virus may lead to a promising new therapy option for patients with peritoneal carcinomatosis, a disseminated intra-abdominal tumour.

  • September 06, 2017

    Diffuse optical spectroscopic texture features can predict breast cancer response to neoadjuvant chemotherapy in locally advanced breast cancer patients before therapy even begins.

  • September 06, 2017

    A team of Canadian cancer researchers has shown that rare, therapy-resistant leukemia stem cells are already present at diagnosis in patients who experience relapses of acute myeloid leukemia (AML).

  • September 06, 2017

    While significant accolades are given to scientists who discover genetic mutations that are linked to cancer, it is equally important to determine factors that are not correlated.

  • September 06, 2017

    Subtype-specific alterations in a driver gene for non-Hodgkin lymphoma (BCL2) is strongly associated with poor patient outcomes after treatment.

  • September 06, 2017

    The discovery of seven new genetic subtypes of ovarian cancer may lead to targeted treatments for women diagnosed with this disease, including those with the most malignant form.

  • September 05, 2017

    The Terry Fox Research Institute has invested nearly $21.5-million to renew three 2017 Terry Fox New Frontiers Program Project Grants (PPGs).

  • June 30, 2017

    Two features articles published by VICE Sports for Canada 150 are calling Terry Fox the most important athlete in Canadian history whose cancer research legacy lives on.

  • June 30, 2017

    New research from a TFRI-funded team suggests screening for lung cancer could save money – and lives – especially if it also identifies other tobacco-related conditions in high-risk individuals.

  • June 22, 2017

    Terry’s dream was to fund research to cure cancer, and he inspired us with that dream. We believe that it is through research that cures to cancer will be found, and survival rates for even the most challenging cancers will continue to increase.

  • May 29, 2017

    Dr. Victor Ling, president and scientific director of The Terry Fox Research Institute, has been recognized by The Vancouver Sun for his breakthrough in fighting drug-resistant cancers.

  • May 24, 2017

    The drug metformin is typically used to treat Type 2 diabetes, and some cancer patients have shown improved outcome when given the drug. A recent study by TFRI’s hypoxia group sheds new light on biomarkers that may indicate the drug’s efficacy in patients.

  • May 24, 2017

    TFRI’s long-funded program project on human leukemia has made groundbreaking progress in the quest to expand human blood stem cells for therapeutic purposes.

  • May 24, 2017

    What if there was a way to predict if leukemia patients would respond to standard treatment or not? A TFRI-funded team has developed a novel, 17-gene signature test from leukemia stem cells (LSCs) that determines just that.

Back to Top